Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nocion Therapeutics

Request full access

Developing novel treatments for silencing neurons

Needham, United StatesFounded 2017Biotech & Life Sciences

About Nocion Therapeutics

Nocion Therapeutics is a biotechnology company focused on developing novel small molecules, known as nocions, to treat conditions such as cough, itch, pain, and inflammation. These nocions specifically target activated sensory neurons, which are responsible for these symptoms, by entering through large pore channels that open in response to external insults. Once inside, nocions block all sodium channels, providing a targeted and sustained effect that traditional small molecule anesthetics cannot achieve. The company's platform is based on the well-understood physiology of nociceptors and aims to offer a more effective treatment for neurogenic inflammation compared to existing approaches. Nocion Therapeutics primarily serves the healthcare market, targeting patients suffering from conditions related to neurogenic inflammation. The business model involves the research and development of these specialized compounds, with revenue generated through partnerships, licensing agreements, and eventual product sales.

Source: Dealroom company data

At a glance

Status
Operational
Employees
19
Open positions
None listed
Dealroom signal
75.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Mar 2024 $62M $248M Osage University Partners · Canaan · F-Prime · Lumira Ventures ↗
EARLY VCOther financing Aug 2021 $7M $28M Undisclosed —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Nocion Therapeutics website traffic

Latest recorded traffic for Nocion Therapeutics is 4.9K monthly website visits, up 36.1% over the last three months. Nocion Therapeutics's team grew 0% over the past year.

Latest monthly visits4.9K 3-month web change+36.1% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nocion Therapeutics in the Needham ecosystem

Live from Dealroom

The Nocion Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

  • Canaan
  • Partners Innovation Fund
  • F-Prime
  • Arkin Capital
  • Monograph Capital
  • Osage University Partners
  • Lumira Ventures
  • Mission BioCapital
  • Mass General Brigham Ventures

Other known investors1 additional known investor

  • Harvard University
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States92.9%
🇨🇦 Canada7.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nocion Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nocion Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.